- Title: Subtitle
- Postibrutinib relapse outcomes for patients with marginal zone lymphoma
- Creators
- Narendranath Epperla - The Ohio State UniversityQiuhong Zhao - The Ohio State UniversitySayan Mullick Chowdhury - The Ohio State UniversityLauren Shea - University of Alabama at BirminghamTamara K Moyo - Levine Cancer InstituteNishitha Reddy - Vanderbilt University Medical CenterJulia Sheets - University of North Carolina at Chapel HillDavid M Weiner - University of PennsylvaniaPraveen Ramakrishnan Geethakumari - Southwestern Medical CenterMalathi Kandarpa - University of MichiganXimena Jordan Bruno - Hospital of the University of PennsylvaniaColin Thomas - Thomas Jefferson University HospitalMichael C Churnetski - Emory UniversityAndrew Hsu - Brown UniversityLuke Zurbriggen - UW Health University HospitalXiao-Wei Cherie Tan - University of Maryland Medical CenterKathryn Lindsey - MUSC Hollings Cancer CenterJoseph Maakaron - University of Minnesota SystemPaolo F Caimi - Cleveland ClinicPallawi Torka - Roswell Park Cancer InstituteCeleste Bello - Moffitt Cancer CenterSabarish Ayyappan - University of IowaTimothy S Oh - Northwestern UniversityReem Karmali - Northwestern UniversitySeo-Hyun Kim - Rush University Medical CenterAnna Kress - Yale UniversityShalin Kothari - Yale UniversityYazeed Sawalha - The Ohio State UniversityBeth Christian - The Ohio State UniversityKevin A David - Rutgers, The State University of New JerseyIrl Brian Greenwell - Medical University of South CarolinaMurali Janakiram - City Of Hope National Medical CenterVaishalee P Kenkre - University of Wisconsin–MadisonAdam J Olszewski - Brown UniversityJonathon B Cohen - Emory UniversityNeil Palmisiano - Thomas Jefferson UniversityElvira Umyarova - University of Vermont Medical CenterRyan A Wilcox - University of MichiganFarrukh T Awan - The University of Texas Southwestern Medical CenterJuan Pablo Alderuccio - Sylvester Comprehensive Cancer CenterStefan K Barta - Hospital of the University of PennsylvaniaNatalie S Grover - University of North Carolina at Chapel HillNilanjan Ghosh - Levine Cancer InstituteNancy L Bartlett - Washington University in St. LouisAlex F Herrera - City Of Hope National Medical CenterGeoffrey Shouse - City Of Hope National Medical Center
- Resource Type
- Letter/Communication
- Publication Details
- Blood advances, Vol.7(1), pp.88-91
- DOI
- 10.1182/bloodadvances.2022008634
- PMID
- 36269847
- PMCID
- PMC9827027
- NLM abbreviation
- Blood Adv
- ISSN
- 2473-9529
- eISSN
- 2473-9537
- Language
- English
- Date published
- 01/10/2023
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984361857402771
Letter/Communication
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Blood advances, Vol.7(1), pp.88-91
01/10/2023
DOI: 10.1182/bloodadvances.2022008634
PMCID: PMC9827027
PMID: 36269847
Abstract
Details
Metrics
8 Record Views